SCHEMBL8309232

SCHEMBL8309232

CC(=O)SCC(C)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11189624 1.00
SCHEMBL11398058 1.00
SCHEMBL11585090 0.79
SCHEMBL11271937 0.77 ALDH1A1 (0.31)
SCHEMBL27971942 0.74 MME (0.41)
SCHEMBL8677748 0.74
SCHEMBL28278690 0.72
SCHEMBL10503553 0.71
SCHEMBL7444407 0.70
SCHEMBL15305490 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0187956-A2 Pharmaceutical composition for the treatment of defects of the gastrointestinal mucous membrane BOEHRINGER INGELHEIM KG (DE) 1986-07-23 EP claimed
EP-0903346-A1 SYDNONE IMINE DERIVATIVES Chugai Seiyaku Kabushiki Kaisha (JP) 1999-03-24 EP disclosed
US-5476791-A Reacting thioacetic acid with methyl methacrylate; contacting the propionate with cells of microorganisms to effect biological and asymmetric hydrolysis; extraction; reacting with L-proline MITSUBISHI RAYON COMPANY, LIMITED (JP) 1995-12-19 US disclosed
EP-0187956-A2 Pharmaceutical composition for the treatment of defects of the gastrointestinal mucous membrane BOEHRINGER INGELHEIM KG (DE) 1986-07-23 EP disclosed